ISMRM Workshops: Learn, Share Research & Network
ISMRM Workshop on
Cancer Imaging:
From Discovery to Diagnosis
01-04 November 2022
Asilomar Conference Grounds, Pacific Grove, CA, USA
Thank you for a great workshop!
Presentation recordings are available below.
Organizers
Co-Chairs:
C. Chad Quarles, Ph.D.
Janine Lupo, Ph.D.
Supporters & Declarations
Overview & Program
Workshop Overview
This workshop, organized by the ISMRM MR of Cancer Working Group, will focus on the development and application of novel MRI/MRS acquisition and analysis technologies for cancer. At this bi-annual workshop, we will address and highlight strategies for successfully traversing the translational pipeline. Topics will include development and validation of new cancer imaging methods, analysis tools and probes, preclinical application, first-in-human studies, image-guided therapies, clinical trial evaluation, quality assurance and benchmarking, and clinical best practices.
The program will feature invited scientific presentations from a diverse group of experts in technical innovation and clinical practice (physicians and SMRT members), in addition to proffered papers and poster sessions. The Bill Negendank Young Investigator Awards, for which students, trainees, and post-doctoral fellows are eligible, will also be awarded based on the quality of the presented work.
Target Audience:
The workshop is designed for basic scientists, physicians, regulators, technologists, students, trainees, and postdoctoral fellows with an interest in cancer MRI/MRS.
Educational Objectives:
Upon completion of this activity, participants should be able to:
Program
Videos, abstracts & syllabi linked below are available to registered attendees only.
Registration & Setup - Tuesday, 01 November 2022
14:00-18:00
On-site registration available
16:00-18:00
Speaker Upload Available
18:00
Dinner for attendees staying at Asilomar
Day 1 - Wednesday, 02 November 2022
07:30
Breakfast for attendees staying at Asilomar
Registration & Speaker Upload Available
08:30
Welcome & Opening Statements
Session 1: Emerging Cancer Imaging Methods & Probes: Preclinical Validation
Moderators: Joel R. Garbow, Ph.D. & Chengyue Wu, Ph.D.
08:40
Kristine Glunde, Ph.D.
Johns Hopkins University
Baltimore, MD, USA
09:10
Pavithra Viswanath, Ph.D.
University of California, San Francisco
San Francisco, CA, USA
Proffered Papers - Oral Session
09:25
Characterizing Tumor Microenvironment in Mouse Models of Pancreatic Ductal Adenocarcinoma Using Quantitative Multiparametric MRI
Ramesh Paudyal, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
09:40
Zheng-Rong Lu, Ph.D.
Case Western Reserve University
Cleveland, OH, USA
09:55
Xiaohong Joe Zhou, Ph.D.
University of Illinois College of Medicine at Chicago
Chicago, IL, USA
10:10
Break & Speaker Upload Available
Session 2: Emerging Cancer Imaging Methods & Probes: First-in-Human Studies
Moderators: Samuel Bobholz, B.Sc. & Masako Kataoka, M.D., Ph.D.
10:30
Henk M. De Feyter, Ph.D.
Yale University of Medicine
New Haven, CT, USA
11:00
Saturation Transfer MRI of Brain Tumor
⨯ Video Permission Withheld
Hye Young Heo, Ph.D.
Johns Hopkins University
Baltimore, MD, USA
Proffered Papers - Oral Session
11:15
Whole-Body MRI for Noninvasive Detection & Therapy Response Assessment: Application in Multiple Myeloma
Sheng-Qing Lin, B.Sc.
University of Texas Southwestern Medical Center
Dallas, TX, USA
11:30
Whole Brain Multi-Parametric Mapping & Lesion Segmentation of Contrast Enhancing Gliomas Without the Injection of Contrast Agent
⨯ Video Permission Withheld
Jing Liu, Ph.D.
University of California, San Francisco
San Francisco, CA, USA
11:45
Application of Ultrafast DCE-MRI to Distinguish Benign & Malignant Breast Lesions in a Clinical Setting
Anum Kazerouni, Ph.D.
University of Washington
Seattle, WA, USA
12:00
Lunch & Speaker Upload Available
Session 3: Clinical Applications of Cancer Imaging: Early Detection, Stratification, Genotyping & Phenotyping
Moderators: Peter S. LaViolette, Ph.D. & T.B.A.
13:30
Radka Stoyanova, Ph.D.
University of Miami
Miami, FL, USA
14:00
Ovidiu Andronesi, M.D., Ph.D.
Massachusetts General Hospital
Charlestown, MA , USA
Proffered Papers - Oral Session
14:15
Mohammad Alhusseini, Ph.D.
University of Miami
Miami, FL, USA
14:30
Pre-Treatment Diffusion Kurtosis Imaging for Predicting Locoregional Failure in Nasopharyngeal Cancer
Ramesh Paudyal, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
14:45
Radio-Pathomic Maps of Glioblastoma Cellularity Highlight Regions Outside Contrast Enhancement that Recur Early
Aleksandra Winiarz, B.Sc.
Medical College of Wisconsin
Milwaukee, WI, USA
15:00
Break & Speaker Upload Available
Power Pitch Session (No CME Available) | Watch the pitches
15:30
Aliya Anil, M.Sc.
Barrow Neurological Institute
Houston, TX, USA
Samuel Bobholz, Ph.D.
Medical College of Wisconsin
Milwaukee, WI, USA
Adrian Breto, B.Sc.
University of Miami
Miami, FL, USA
Collin Buelo, M.Sc.
University of Wisconsin-Madison
Madison, MI, USA
Sanjeev Chawla, Ph.D., DABMP
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA, USA
Savannah Duenweg, B.Sc.
Medical College of Wisconsin
Milwaukee, WI, USA
Savannah Duenweg, B.Sc.
Medical College of Wisconsin
Milwaukee, WI, USA
Amaresha Konar Shridhar, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
Yan Li, Ph.D.
University of California San Francisco
San Francisco, CA, USA
Chemical Exchange Saturation Transfer (CEST) MRI for Differentiating Radiation Necrosis from Tumour Progression in Brain Metastasis – Application in a Clinical Setting
⨯ Video Permission Withheld
Leedan Murray, B.Sc.
Sunnybrook Research Institute
Toronto, ON, Canada
Calin Nicolescu, B.Sc.
Case Western Reserve University
Cleveland, OH, USA
Sofya Osharovich, B.Sc.
University of Pennsylvania
Philadelphia, PA, USA
Sule Sahin, B.Sc.
University of California, San Francisco
San Francisco, CA, USA
Eddy Solomon, Ph.D.
Weill Cornell Medicine
New York, NY, USA
Kyu-Ho Song, Ph.D.
Washington University in St. Louis
St. Louis, MO, USA
Margaret Stebbins, B.Sc.
Medical College of Wisconsin
Milwaukee, WI, USA
Aleksandra Winiarz, B.Sc.
Medical College of Wisconsin
Milwaukee, WI, USA
Limin Zhou, B.Sc.
University of Texas, Southwestern Medical Center
Dallas, TX, USA
Ante Zhu, Ph.D.
General Electric Research
Niskayuna, NY, USA
16:30
Poster Viewing Session (No CME Available)
Drinks
18:00
Adjournment
Dinner for attendees staying at Asilomar
Day 2 - Thursday, 03 November 2022
07:30
Registration & Speaker Upload Available
Breakfast for attendees staying at Asilomar
08:30
The Negendank Lecture: Magnetic Resonance Metabolic Imaging of Brain Tumors -- Detecting Drivers of Gliomagenesis
Sabrina Ronen, Ph.D.
University of California, San Francisco
San Francisco, CA, USA
Session 4: Preclinical Applications: Novel Therapeutic Paradigms
Moderators: Jonghyun Bae, M.Sc. & Harish Poptani, Ph.D.
09:00
Heike E. Daldrup-Link, M.D., Ph.D.
Stanford University
Stanford, CA, USA
09:30
Metabolic Modulation Towards Improved Outcome in Cancer Therapy
⨯ Video Permission Withheld
Kavindra Nath, Ph.D.
University of Pennsylvania
Philadelphia, PA, USA
Proffered Papers - Oral Session
09:45
Xiaoyu Jiang, Ph.D.
Vanderbilt University Institute of Imaging Science
Nashville, TN, USA
10:00
Yuancheng Li, Ph.D.
Emory University School of Medicine
Atlanta, GA, USA
10:15
Break & Speaker Upload Available
Session 5: Clinical Applications of Cancer Imaging: Biomarkers for Predicting & Monitoring Therapy Response
Moderators: E. James Delikatny, Ph.D. & Eddy Solomon, Ph.D.
10:45
Savannah Partridge, Ph.D.
University of Washington
Seattle, WA, USA
Proffered Papers - Oral Session
11:30
Compartmental Analysis of Glioblastoma Cellularity Using Autopsy-Based Radio-Pathomic Maps Identifies IDH1 Mutation Status
Samuel Bobholz, Ph.D.
Medical College of Wisconsin
Milwaukee, WI, USA
11:45
MRI-Based Digital Twins Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Chengyue Wu, Ph.D.
The University of Texas at Austin
Austin, TX, USA
12:00
Longitudinal Multi-Parametric WB-MRI can be used to Quantify the Effects of Immunotherapy on Normal Tissues in Patients with Metastatic Melanoma
Annemarie Knill, B.Sc.
The Institute of Cancer Research
London, England, UK
12:15
Lunch & Speaker Upload Available
13:30
Break / Activities (until 16:00)
Session 6: Clinical Applications of Cancer Imaging: Image-Guided & Adaptive Therapy
Moderators: C. Chad Quarles, Ph.D. & Junzhong Xu, Ph.D.
16:00
Yue Cao, Ph.D.
University of Michigan
Ann Arbor, MI, USA
16:30
A Multi-Institutional Pilot Study of Spectroscopy-Guided Radiation Dose Escalation in Patients with Glioblastoma
Saumya Gurbani, Ph.D.
Emory University
Atlanta, GA, USA
Proffered Papers - Oral Session
16:45
Longitudinal Changes of Multiparametric MRI Features are Associated with Radiation Therapy Outcome for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy
⨯ Video Permission Withheld
Ahmad Algohary, Ph.D.
University of Miami
Miami, FL, USA
17:00
Incorporating Predictions of Tumor Recurrence for Radiation Target Volume Definition Using Pre-Treatment Metabolic & Physiologic MRI & Machine Learning in Patients with Glioblastoma
Nate Tran, M.Sc.
University of California, San Francisco
San Francisco, CA, USA
17:15
Brandy Reed, M.B.A.,R.T.(R)(MR)
University of Texas MD Anderson Cancer Center
Houston, TX, USA
17:30
Adjournment
18:00
Dinner for attendees staying at Asilomar
Day 3 - Friday, 04 November 2022
07:30
Registration & Speaker Upload Available
Breakfast for attendees staying at Asilomar
Session 7: Cancer Image Analysis: Omics, Mathematical Modeling & Deep Learning
Moderators: Wen Li, Ph.D. & Janine Lupo, Ph.D.
09:00
Thomas Yankeelov, Ph.D.
University of Texas at Austin
Austin, TX, USA
Proffered Papers - Oral Session
09:45
Suneeta Chaudhary, Ph.D.
Cornell University
New York, NY, USA
10:00
Spatial Mapping of Treatment-Induced Effects in Recurrent Glioblastoma with Multi-Parametric MRI & Deep Learning
Jacob Ellison, B.Sc., M.Sc.
University of California, San Francisco
San Francisco, CA, USA
10:15
Break & Speaker Upload Available
Session 8: Pathways for Clinical Translation: Quality Assurance, Standardization & Benchmarking
Moderators: Savannah Duenweg, B.Sc., & Alexey Samsonov, Ph.D.
10:40
Amita Shukla-Dave, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
11:10
Kathryn Keenan, Ph.D.
National Institute of Standards & Technology
Boulder, CO, USA
Proffered Papers - Oral Session
11:25
Qualitative & Quantitative Performance Evaluation of Synthetic MRI: An Emerging Rapid Method for Head & Neck Imaging
Amaresha Konar Shridhar, Ph.D.
Memorial Sloan Kettering Cancer Center
New York, NY, USA
11:40
Digital Reference Object (DRO) Toolkit for Evaluation of Quantitative Breast Dynamic Contrast-Enhanced (DCE)-MRI Methods
Jonghyun Bae, M.Sc.
Weill Cornell Medicine
New York, NY, USA
11:55
Closing Remarks
12:00
Adjournment
Lunch available at Asilomar Cafeteria (until 13:00)
🡄 Return to Future Workshops Page | Questions? Contact us at info@ismrm.org.
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Organizing Committee
×
Co-Chairs:
C. Chad Quarles, Ph.D.
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Janine Lupo, Ph.D.
University of California San Francisco, San Francisco, CA, USA
Committee Members
Laura C. Bell, Ph.D.
Genentech, South San Francisco, CA, USA
Masako Kataoka, M.D., Ph.D.
Kyoto University Hospital, Kyoto, Japan
Sungheon Gene Kim, Ph.D.
New York University School of Medicine, New York, NY, USA
Peter S. LaViolette, Ph.D.
Medical College of Wisconsin, Milwaukee, WI, USA
Gigin Lin, M.D., Ph.D.
Chang Gung Memorial Hospital, Linkou, Taiwan
Esin Öztürk-Işık, Ph.D.
Bogaziçi University, Istanbul, Turkey
Harish Poptani, Ph.D.
University of Liverpool, Liverpool, England, UK
Simon P. Robinson, Ph.D.
The Institute of Cancer Research, London, London, England, UK
Rhys A. Slough, M.Sc.
Cambridge University Hospital, Cambridge, England, UK
Janine P. Wijnen, Ph.D.
University Medical Centre Utrecht, Utrecht, The Netherlands
Supporters
×
The ISMRM wishes to thank the following supporters for their contributions to the ISMRM Workshop on Cancer Imaging: From Discovery to Diagnosis:
Tier Ⅱ
Tier Ⅰ
The International Society for Magnetic Resonance in Medicine (ISMRM) acknowledges and thanks its Corporate Members for their continued support of the Society:
GOLD CORPORATE MEMBERS
Canon Medical | Olea Medical
GE Healthcare
Philips Healthcare
Siemens Healthineers
BRONZE CORPORATE MEMBERS
Bruker
Fujifilm Healthcare
United Imaging Healthcare
ASSOCIATE CORPORATE MEMBERS
Faculty Declarations of Financial Interests
×
The ISMRM is committed to:
Therefore, it is the policy of the Society that any person who has influence over the content of an educational activity must disclose any real or apparent financial interest or other relationship (i.e., grant, research support, consulting fee, royalty, honorarium for promotional speakers’ bureau, ownership interest) that the individual may have with the manufacturers, distributors or providers of any commercial products or services that may be discussed in the presentation.
The ISMRM does not imply that such financial interests or relationships are inherently improper or that such interests or relationships would prevent the speaker or organizer from making an objective contribution. However, it is imperative that such financial interests or relationships be identified so that potential conflicts can be resolved before the program, and participants at the activity may have these facts fully disclosed in advance. It then remains for the audience to determine whether an individual’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.
Following are the names of all speakers, committee members and other organizers who had influence over the program content. If individuals have disclosed real or apparent financial interests or relationships with regard to the subject matter of this meeting, the interests or relationships are described. All potentially relevant relationships have been mitigated appropriately.
Invited Faculty: | |
Ovidiu C. Andronesi, M.D., Ph.D. | No relationships to disclose |
Yue Cao, Ph.D. | Disclosure not provided |
Heike E. Daldrup-Link, M.D., Ph.D. | Grants & Research Support: MegaPro Biomedical, NIH, Others; Employment: Stanford University; Royalty: Monasteria Press LLC. |
Henk M. De Feyter, Ph.D. | No relationships to disclose |
Mary Ellen Giger, Ph.D. | Grants & Research Support: Qlarity Imaging; Editor-in-Chief: Journal of Medical Imaging, SPIE; Honoraria |
Kristine Glunde, Ph.D. | No relationships to disclose |
Saumya Gurbani, Ph.D. | No relationships to disclose |
Hye Young Heo, Ph.D. | No relationships to disclose |
Kathryn Keenan, Ph.D. | No relationships to disclose |
Kavindra Nath, Ph.D. | No relationships to disclose |
Savannah Partridge, Ph.D. | Gants/Research Support: General Electric, Philips; Consulting: Guerbet |
Brandy Reed, M.B.A.,R.T.(R)(MR) | No relationships to disclose |
Viola Rieke, Ph.D. | No relationships to disclose |
Sabrina Ronen, Ph.D. | No relationships to disclose |
Amita Shukla-Dave, Ph.D. | No relationships to disclose |
Radka Stoyanova, Ph.D. | No relationships to disclose |
Pallavi Tiwari, Ph.D. | No relationships to disclose |
Pavithra Viswanath, Ph.D. | Disclosure not provided |
Thomas E. Yankeelov, Ph.D. | No relationships to disclose |
Xiaohong Joe Zhou, Ph.D., DABR, DABMP | No relevant relationships to disclose |
Organizers | |
Laura C. Bell, Ph.D. | Disclosure not provided |
Masako Kataoka, M.D., Ph.D. | No relevant relationships to disclose |
Sungheon Gene Kim, Ph.D. | No relevant relationships to disclose |
Peter S. LaViolette, Ph.D. | No relevant relationships to disclose |
Gigin Lin, M.D., Ph.D. | No relationships to disclose |
Janine M. Lupo, Ph.D. | Grants & Research Support: General Electric |
Esin Öztürk-Işık, Ph.D. | No relationships to disclose |
Harish Poptani, Ph.D. | No relationships to disclose |
C. Chad Quarles, Ph.D. | Grants/Research Support: Philips, Blue Earth Diagnostics |
Simon P. Robinson, Ph.D. | No relationships to disclose |
Rhys A. Slough, M.Sc. | No relationships to disclose |
Jannie P. Wijnen, Ph.D. | No relationships to disclose |
Moderators | |
Jonghyun Bae, M.Sc. | Grants/Research Support: NIH R01CA160620, R01CA219964, UH3CA228699 |
Samuel Bobholz, B.Sc. | No relationships to disclose |
E. James Delikatny, Ph.D. | No relationships to disclose |
Savannah Duenweg, B.Sc. | No relationships to disclose |
Joel R. Garbow, Ph.D. | No relationships to disclose |
Masako Kataoka, M.D., Ph.D. | No relevant relationships to disclose |
Peter S. LaViolette, Ph.D. | Disclosure not provided |
Wen Li, Ph.D. | No relationships to disclose |
Janine Lupo, Ph.D. | Grants/Research Support: General Electric |
Harish Poptani, Ph.D. | No relationships to disclose |
C. Chad Quarles, Ph.D. | Grants/Research Support: Philips, Blue Earth Diagnostics |
Alexey Samsonov, Ph.D. | No relationships to disclose |
Chengyue Wu, Ph.D. | No relationships to disclose |
Junzhong Xu, Ph.D. | No relationships to disclose |
Staff | |
Rhiannon Pinson | No relationships to disclose |
Melissa Simcox | No relationships to disclose |
Certificate of Participation
×
This workshop does not offer CME credits.
To obtain your Certificate of Participation after the workshop has ended, log in to the ISMRM membership portal at www.ismrm.org, then click the [Session Evaluations for Certificates] menu button and follow the instructions provided.